Precision Biosciences Inc Stock Ownership - Who owns Precision Biosciences?

Insider buying vs selling

Have Precision Biosciences Inc insiders been buying or selling?
Dario ScimecaGeneral Counsel and Secretary2023-06-0813,361$0.75
Alan ListChief Medical Officer2023-04-277,771$0.79
Michael AmorosoPresident and CEO2023-03-2246,999$0.82
John Alexander KellyChief Financial Officer2023-03-1720,000$0.86
Alan ListChief Medical Officer2023-03-069,473$1.07
Dario ScimecaGeneral Counsel and Secretary2023-03-0612,172$1.07
J. Jefferson SmithChief Research Officer2023-02-2812,157$0.95
John Alexander KellyChief Financial Officer2023-02-2811,605$0.95
Dario ScimecaGeneral Counsel and Secretary2023-02-282,163$0.95
Michael AmorosoPresident and CEO2022-10-1711,006$1.32

1 of 2

DTIL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DTIL insiders and whales buy or sell their stock.

DTIL Shareholders

What type of owners hold Precision Biosciences Inc stock?
Pharma Ag Novartis10.90%12,407,440$9.38MInsider
Great Point Partners LLC7.12%8,099,799$6.12MInstitution
Capital World Investors5.90%6,715,043$5.08MInstitution
Vanguard Group Inc4.17%4,739,819$3.58MInstitution
Venbio Global Strategic Fund LP3.75%4,265,141$3.22MInsider
Derek Jantz3.56%4,055,174$3.07MInsider
Fmr LLC3.29%3,738,248$2.83MInsider
Chi Advisors LLC3.05%3,469,820$2.62MInstitution
Acadian Asset Management LLC2.55%2,905,818$2.20MInstitution
Citadel Advisors LLC2.49%2,837,414$2.15MInstitution

1 of 3

DTIL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DTIL42.52%26.10%Net BuyingNet Selling
VTVT3.41%57.36%Net Buying
DMAC6.30%29.21%Net BuyingNet Buying

Precision Biosciences Stock Ownership FAQ

Who owns Precision Biosciences?

Precision Biosciences (NASDAQ: DTIL) is owned by 42.52% institutional shareholders, 26.10% Precision Biosciences insiders, and 31.38% retail investors. Pharma Ag Novartis is the largest individual Precision Biosciences shareholder, owning 12.41M shares representing 10.90% of the company. Pharma Ag Novartis's Precision Biosciences shares are currently valued at $9.08M.

If you're new to stock investing, here's how to buy Precision Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.